Bahrt Kenneth 4
4 · SAVIENT PHARMACEUTICALS INC · Filed May 1, 2013
Insider Transaction Report
Form 4
Bahrt Kenneth
SVP, Chief Medical Officer
Transactions
- Sale
Common Stock
2013-04-30$0.74/sh−1,250$925→ 178,211 total
Footnotes (1)
- [F1]These shares were sold automatically pursuant to a binding contract under Rule 10b5-1 of the Securities Exchange Act of 1934 to cover tax withholding obligations in connection with the vesting of restricted stock granted on July 31, 2011.